Dr. Ghosh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 704-355-5800- Is this information wrong?
Summary
- I trained in Hematology and Oncology at Johns Hopkins University, School of medicine and stayed as faculty in Oncology after completion of my training. Since January 2014, I have lead the Lymphoma Division at Levine Cancer Institute, Carolinas HealthCare system.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2004 - 2007
KJ Somaiya Medical CollegeClass of 1997
Certifications & Licensure
NC State Medical License 2013 - 2024
MD State Medical License 2008 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma Start of enrollment: 2012 Apr 01
- Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma Start of enrollment: 2012 Apr 01
- Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2014 Mar 13
Publications & Presentations
PubMed
- 2 citationsTwo-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001.Jeremy S Abramson, M Lia Palomba, Leo I Gordon, Matthew Lunning, Michael Wang, Jon Arnason, Enkhtsetseg Purev, David G Maloney, Charalambos Andreadis, Alison Sehgal, S...> ;Blood. 2024 Feb 1
- Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter...Michael Wang, Tanya Siddiqi, Leo I Gordon, Manali Kamdar, Matthew Lunning, Alexandre V Hirayama, Jeremy S Abramson, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Chara...> ;Journal of Clinical Oncology. 2024 Apr 1
- 3 citationsMosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.Budde, L., Olszewski, A., Assouline, S., Lossos, I., Diefenbach, C., Kamdar, M., Ghosh, N., Modi, D., Sabry, W., Naik, S., Mehta, A., Nakhoda, S., Smith, S., Dorritie,...> ;Nature Medicine. 2024 Jan 1
- Join now to see all
Journal Articles
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s LymphomaMark P Chao, Sonali M Smith, Ranjana Advani, Ian Flinn, Ravindra Majeti, Nancy L Bartlett, Leslie Popplewell, Justin Kline, Nilanjan Ghosh, Ann LaCasce, The New England Journal of Medicine
Abstracts/Posters
- Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell LymphomaNilanjan Ghosh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)Nilanjan Ghosh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes Following Early Relapse in Patients with Mantle Cell LymphomaNilanjan Ghosh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Chronic Lymphocytic Leukemia Treatment Patterns, Dosing, and Sequencing in the Era of Novel Targeted Therapies: Interim Analysis Results from the Prospective informCLL...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Chronic Lymphocytic Leukemia Treatment Patterns, Dosing, and Sequencing in the Era of Novel Targeted Therapies: Interim Analysis Results from the Prospective informCLL...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Real World Evidence in Relapsed/Refractory Classical Hodgkin Lymphoma Patients Who Are Ineligible for Stem Cell Transplant in the United States (US)Clinically Relevant...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Common Conditioning Regimen Has Highest Mortality Risk, Lowest OS for NHL Patients Undergoing TransplantAugust 24th, 2020
Hands-on Approach Addresses Barriers to Care for DLBCL PatientsJanuary 20th, 2020
What’s in Store for CAR T Cell Therapy in Relapsed/Refractory Lymphoma?May 31st, 2019- Join now to see all
Hospital Affiliations
Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
